600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01345

Synthetic patientNBL-101 · Day 108 · 55–64 · M · baseline S12Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S12
  2. Day 78 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 78.

Primary contributors, last 14 days
  • Nutritional resilience-11
  • GI instability+5
  • Toxicity+5
  • Treatment adherence-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    30.2/100
    improving · -5.9 vs previous 14 d
    Toxicity
    Blood
    14.9/100
    improving · -6.4 vs previous 14 d
    Sleep quality
    Wearable
    48.5/100
    improving · +6.7 vs previous 14 d
    Energy level
    Daily log
    5.4/10
    improving · +0.4 vs previous 14 d
    Stress level
    Daily log
    4.2/10
    improving · -0.5 vs previous 14 d
    Steps
    Wearable
    5,715
    stable · +175 vs previous 14 d
    Adherence
    Companion
    81.2 %
    worsening · -6.3 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 55 from the failing basin, 50 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    Would not help
    • Nothing clearly counter-productive in the record.
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Histamine load
      -1.8no signal · 27%
    • Simple carbohydrates
      -1.4no signal · 25%
    • Alcohol
      -1.2no signal · 20%
    • Insoluble fibre
      -1no signal · 19%
    • Dietary fat load
      +0.2no signal · 15%
    • Spicy / capsaicin
      +0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
      DNA
      Fictional pharmacogenomic panel
      • CYP2D6 Normal metabolizer
        Expected exposure
      • MTHFR C677T
        Reduced folate turnover
      Microbiome
      Shannon diversity 4.3 · butyrate capacity 66/100
      • Akkermansia muciniphilaNormal
      • Faecalibacterium prausnitziiNormal
      • Bacteroides fragilisNormal
      • Bifidobacterium longumLow
      • EnterobacteriaceaeNormal
      Wearable, last 14 days
      daily evolution fed into the runtime
      HRV
      47 ms
      Sleep
      8.0 h
      Steps
      7,021
      Resting HR
      60 bpm
      Daily log: GI score 30, nutritional resilience 56, adherence 81.

      What this patient sees in NostraAI

      The content that steers the trajectory: what to eat, what to do, what to take.

      Open companion preview
      What to eat
      • Keep meals regular; three to four moderate portions spaced through the day
      • Include a cooked vegetable portion with each main meal
      • Keep fibre steady; no new sources this week
      • Avoid known triggers for now: fried or oily food, dairy, alcohol
      What to do
      • Log the daily check-in; one line is enough
      • Keep the current walking rhythm
      • Keep the sleep window steady
      • Keep hydration steady: small amounts through the day rather than large volumes at once
      What to take
      • Take the scheduled dose as agreed with your care team
      • No additional supplements this week
      • Fictional demo item: continue vitamin D as before

      284 biologically similar trajectories

      Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

      Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
      PatientSimilarityBaselineInterventionOutcomeResponse today
      P-0139749%S03——28
      P-0172247%S09——36
      P-0184647%S01——37
      P-0135046%S19BR-03no change34
      P-0167946%S12AD-05no change39
      P-0140145%S15——34
      P-0148344%S14AD-05no change35
      P-0181644%S01——35
      P-0131342%S01BR-03improved32
      P-0136342%S11——29
      P-0141541%S12——32
      P-0182941%S11——31